Historical record - last NADAC effective date: 10/19/2016
Product Information
CYCLOBENZAPRINE 10 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0234 per EA under NDC 65862019101. Its NADAC has been published 156 times since Nov 28, 2013.
FDA first approved this application on Sep 26, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862019101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
10/19/2016
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078643FDA Approved
9/26/2008
TE Code
AB
On Market Since
9/26/2008
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 10 MG TABLET has been published 156 times since Nov 28, 2013, and over the history we have for it it has risen 4.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0234 per EA |
|---|---|
| All-time high | $0.0305 (Feb 12, 2014) |
| All-time low | $0.0216 (Jun 22, 2016) |
| Median price | $0.0235 |
| Average price | $0.0239 |
| Largest weekly change | +23.7% (Jan 22, 2014) |
| Weeks tracked | 156 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+4.6%
Last surveyed Nov 16, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 10 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0234 per EA (NDC 65862019101), effective Nov 16, 2016.
How has the price of CYCLOBENZAPRINE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has risen 4.6%. It has been tracked across 156 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 10 MG TABLET?
Since Nov 28, 2013, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has ranged from a low of $0.0216 (Jun 22, 2016) to a high of $0.0305 (Feb 12, 2014), with a median of $0.0235 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 10 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOBENZAPRINE 10 MG TABLET, is $0.0169 per EA — about 28% below CYCLOBENZAPRINE 10 MG TABLET.
Who manufactures CYCLOBENZAPRINE 10 MG TABLET?
CYCLOBENZAPRINE 10 MG TABLET (NDC 65862019101) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.